ps18 (Phoenix Pharmaceuticals)
Structured Review

Ps18, supplied by Phoenix Pharmaceuticals, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ps18/product/Phoenix Pharmaceuticals
Average 86 stars, based on 1 article reviews
Images
1) Product Images from "Prosaposin in CNS health and disease, metabolic stress and exercise adaptation"
Article Title: Prosaposin in CNS health and disease, metabolic stress and exercise adaptation
Journal: Journal of Molecular Medicine (Berlin, Germany)
doi: 10.1007/s00109-026-02643-3
Figure Legend Snippet: Overview of prosaptide peptides derived from the saposin C domain of prosaposin (PSAP) and their tested therapeutic applications. The full saposin C sequence is shown at the top, with the neurotrophic region ( LIDNNKTEKEIL ) highlighted in green and underlined. Left panel: Sequences of various bioengineered or truncated prosaptide peptides tested in previous studies. Conservative amino acid substitutions (*) and lysine deletions (-) are indicated. Bioactivity is noted where tested. Right panel: Mapping of each prosaptide or full saposin (A–D) to specific disease-relevant therapeutic conditions, including oxidative stress, trauma/injury, ischemia, synucleinopathies, diabetes, allodynia, drug-induced toxicity, and Alzheimer’s disease-related Aβ/tau pathology. Checkboxes indicate whether the peptide has been evaluated in vitro, in vivo, or both. Peptides derived from the neurotrophic region, such as TX14(A), 769, and PS18, show diverse functional relevance across multiple disease models. Created with BioRender.com
Techniques Used: Derivative Assay, Sequencing, In Vitro, In Vivo, Functional Assay
